ReviewDiabetes, obesity & metabolism2025
Biosimilar insulins: Narrative review of the regulatory framework and registration studies.
Tim Heise et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it